Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

What is the purpose of this trial?

The purpose of the study is to evaluate the hypothesis that benzodiazapine inverse agonist drugs might be developed to reverse signs of ethanol intoxication and, perhaps to reduce drinking.


Participation Guidelines

Ages: 21 - 35 years

Gender: Both


Department of Veterans Affairs

Start Date: 07/16/2009

End Date: 06/30/2016

Last Updated: 02/22/2018

Study HIC#: 0906005383

Get Involved

For more information about this study, contact:
Christina Luddy
+1 203-932-5711

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image